Suppr超能文献

优化对乙酰氨基酚处方以实现更安全、更环保且具成本效益的护理:来自一个正在进行的急诊科质量改进项目的经验教训。

Optimising Paracetamol Prescribing for Safer, Greener, and Cost-Effective Care: Lessons From an Ongoing Emergency Department Quality Improvement Project.

作者信息

Lakshmanan Vijay, Rosser Michael

机构信息

Hospital Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, GBR.

Emergency Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, GBR.

出版信息

Cureus. 2025 Sep 11;17(9):e92108. doi: 10.7759/cureus.92108. eCollection 2025 Sep.

Abstract

Paracetamol is one of the most frequently prescribed analgesics in emergency departments (EDs). While intravenous (IV) and oral formulations provide similar analgesic effects, IV paracetamol is more expensive and has a carbon footprint several-fold higher than oral administration. In patients who can take oral medication, the oral route is safer, greener, and more cost-effective. At Royal Preston Hospital in Preston, UK, the baseline audit data from December 2022 to November 2023 revealed that IV paracetamol accounted for approximately 38% of all 1 g paracetamol doses prescribed in the ED. Following informal teaching sessions and staff engagement, a re-audit from February to April 2024 demonstrated no significant reduction in IV use. A further audit from May 2024 to March 2025 revealed no significant reduction in IV paracetamol use, with prescribing rates continuing to hover around 35% to 40% across most months. These findings highlight that early educational interventions can influence prescribing behavior but may be insufficient to deliver lasting change. To build on this work, a structured quality improvement (QI) approach was adopted to implement more targeted and sustainable interventions, including formal teaching, visual prompts, and regular feedback cycles. By encouraging appropriate use of oral paracetamol, this project aims to reduce unnecessary IV prescribing while improving patient safety, lowering costs, and contributing to environmentally sustainable practice. Importantly, this remains an ongoing, multi-cycle initiative, with a third round of data collection commencing in August 2025. This QI report aims not only to outline the effectiveness and sustainability impact of optimizing paracetamol prescribing but also to demonstrate how similar projects can be replicated across various other healthcare departments worldwide. Such initiatives have the potential to promote safer, greener, and more cost-effective care with global relevance.

摘要

对乙酰氨基酚是急诊科最常开具的镇痛药之一。虽然静脉注射(IV)制剂和口服制剂具有相似的镇痛效果,但静脉注射对乙酰氨基酚更昂贵,且碳足迹比口服给药高出几倍。对于能够口服药物的患者,口服途径更安全、更环保且更具成本效益。在英国普雷斯顿的皇家普雷斯顿医院,2022年12月至2023年11月的基线审核数据显示,静脉注射对乙酰氨基酚约占急诊科开具的所有1克对乙酰氨基酚剂量的38%。在进行非正式教学课程和员工参与活动后,2024年2月至4月的重新审核表明静脉注射的使用量没有显著减少。2024年5月至2025年3月的进一步审核显示,静脉注射对乙酰氨基酚的使用量没有显著减少,在大多数月份,处方率持续徘徊在35%至40%左右。这些发现凸显出早期教育干预可以影响处方行为,但可能不足以带来持久的改变。为在此基础上开展工作,采用了结构化质量改进(QI)方法来实施更具针对性和可持续性的干预措施,包括正式教学、视觉提示和定期反馈循环。通过鼓励适当使用口服对乙酰氨基酚,该项目旨在减少不必要的静脉注射处方,同时提高患者安全性、降低成本并促进环境可持续实践。重要的是,这仍然是一项正在进行的多周期倡议,第三轮数据收集于2025年8月开始。这份QI报告不仅旨在概述优化对乙酰氨基酚处方的有效性和可持续性影响,还旨在展示如何在全球其他各个医疗部门复制类似项目。此类倡议有可能在全球范围内推广更安全、更环保且更具成本效益的医疗服务。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da93/12426579/198ac030ae8c/cureus-0017-00000092108-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验